Results from differential expression of DCBLD2 across different tumor stages showed that this gene was significantly upregulated in highly malignant pathological tumors including CHOL, HNSC, KIRP, LUSC, and THCA (p < 0.05) (Figure 2C). The gene discussed is DCBLD2; the disease is neoplasm.